Advanced Renal Cell Carcinoma: Lenvatinib Plus Pembrolizumab or Everolimus
Received Date: Mar 15, 2022 / Published Date: Apr 12, 2022
Citation: Chesang J (2022) Advanced Renal Cell Carcinoma: Lenvatinib Plus Pembrolizumab or Everolimus. Current Trends Gynecol Oncol, 7: 112. Doi: 10.4172/ctgo.1000112
Copyright: © 2022 Chesang J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1165
- [From(publication date): 0-2022 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 843
- PDF downloads: 322